Global Cancer Biopsy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cancer Biopsy market size was valued at US$ million in 2023. With growing demand in downstream market, the Cancer Biopsy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cancer Biopsy market. Cancer Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Biopsy market.
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
Key Features:
The report on Cancer Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Biopsy market. It may include historical data, market segmentation by Type (e.g., Tissue Biopsies, Liquid Biopsies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Biopsy industry. This include advancements in Cancer Biopsy technology, Cancer Biopsy new entrants, Cancer Biopsy new investment, and other innovations that are shaping the future of Cancer Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Biopsy market.
Market Segmentation:
Cancer Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cancer Biopsy market size was valued at US$ million in 2023. With growing demand in downstream market, the Cancer Biopsy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cancer Biopsy market. Cancer Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Biopsy market.
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
Key Features:
The report on Cancer Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Biopsy market. It may include historical data, market segmentation by Type (e.g., Tissue Biopsies, Liquid Biopsies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Biopsy industry. This include advancements in Cancer Biopsy technology, Cancer Biopsy new entrants, Cancer Biopsy new investment, and other innovations that are shaping the future of Cancer Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Biopsy market.
Market Segmentation:
Cancer Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Tissue Biopsies
- Liquid Biopsies
- Others
- Breast Cancer
- Colorectal Cancer
- Cervical Cancers
- Lung Cancers
- Prostate Cancers
- Skin Cancers
- Blood Cancers
- Kidney Cancers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qiagen N.V.
- Illumina, Inc.
- ANGLE Plc
- Myriad Genetics
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- Lucence Diagnostics Pte. Ltd.
- GRAIL, Inc.
- Guardant Health
- Exact Sciences Corporation
- Freenome Holdings, Inc.
- Oncimmune
- Chronix Biomedical, Inc.
- Personal Genome Diagnostics Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Biopsy Market Size 2019-2030
2.1.2 Cancer Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Biopsy Segment by Type
2.2.1 Tissue Biopsies
2.2.2 Liquid Biopsies
2.2.3 Others
2.3 Cancer Biopsy Market Size by Type
2.3.1 Cancer Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Biopsy Market Size Market Share by Type (2019-2024)
2.4 Cancer Biopsy Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Cervical Cancers
2.4.4 Lung Cancers
2.4.5 Prostate Cancers
2.4.6 Skin Cancers
2.4.7 Blood Cancers
2.4.8 Kidney Cancers
2.4.9 Others
2.5 Cancer Biopsy Market Size by Application
2.5.1 Cancer Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Biopsy Market Size Market Share by Application (2019-2024)
3 CANCER BIOPSY MARKET SIZE BY PLAYER
3.1 Cancer Biopsy Market Size Market Share by Players
3.1.1 Global Cancer Biopsy Revenue by Players (2019-2024)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER BIOPSY BY REGIONS
4.1 Cancer Biopsy Market Size by Regions (2019-2024)
4.2 Americas Cancer Biopsy Market Size Growth (2019-2024)
4.3 APAC Cancer Biopsy Market Size Growth (2019-2024)
4.4 Europe Cancer Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Biopsy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Biopsy Market Size by Country (2019-2024)
5.2 Americas Cancer Biopsy Market Size by Type (2019-2024)
5.3 Americas Cancer Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Biopsy Market Size by Region (2019-2024)
6.2 APAC Cancer Biopsy Market Size by Type (2019-2024)
6.3 APAC Cancer Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Biopsy by Country (2019-2024)
7.2 Europe Cancer Biopsy Market Size by Type (2019-2024)
7.3 Europe Cancer Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Biopsy by Region (2019-2024)
8.2 Middle East & Africa Cancer Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER BIOPSY MARKET FORECAST
10.1 Global Cancer Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Cancer Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Biopsy Forecast
10.1.3 APAC Cancer Biopsy Forecast
10.1.4 Europe Cancer Biopsy Forecast
10.1.5 Middle East & Africa Cancer Biopsy Forecast
10.2 Americas Cancer Biopsy Forecast by Country (2025-2030)
10.2.1 United States Cancer Biopsy Market Forecast
10.2.2 Canada Cancer Biopsy Market Forecast
10.2.3 Mexico Cancer Biopsy Market Forecast
10.2.4 Brazil Cancer Biopsy Market Forecast
10.3 APAC Cancer Biopsy Forecast by Region (2025-2030)
10.3.1 China Cancer Biopsy Market Forecast
10.3.2 Japan Cancer Biopsy Market Forecast
10.3.3 Korea Cancer Biopsy Market Forecast
10.3.4 Southeast Asia Cancer Biopsy Market Forecast
10.3.5 India Cancer Biopsy Market Forecast
10.3.6 Australia Cancer Biopsy Market Forecast
10.4 Europe Cancer Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Cancer Biopsy Market Forecast
10.4.2 France Cancer Biopsy Market Forecast
10.4.3 UK Cancer Biopsy Market Forecast
10.4.4 Italy Cancer Biopsy Market Forecast
10.4.5 Russia Cancer Biopsy Market Forecast
10.5 Middle East & Africa Cancer Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Biopsy Market Forecast
10.5.2 South Africa Cancer Biopsy Market Forecast
10.5.3 Israel Cancer Biopsy Market Forecast
10.5.4 Turkey Cancer Biopsy Market Forecast
10.5.5 GCC Countries Cancer Biopsy Market Forecast
10.6 Global Cancer Biopsy Forecast by Type (2025-2030)
10.7 Global Cancer Biopsy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Information
11.1.2 Qiagen N.V. Cancer Biopsy Product Offered
11.1.3 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Qiagen N.V. Main Business Overview
11.1.5 Qiagen N.V. Latest Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Information
11.2.2 Illumina, Inc. Cancer Biopsy Product Offered
11.2.3 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina, Inc. Main Business Overview
11.2.5 Illumina, Inc. Latest Developments
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Information
11.3.2 ANGLE Plc Cancer Biopsy Product Offered
11.3.3 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ANGLE Plc Main Business Overview
11.3.5 ANGLE Plc Latest Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Information
11.4.2 Myriad Genetics Cancer Biopsy Product Offered
11.4.3 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Myriad Genetics Main Business Overview
11.4.5 Myriad Genetics Latest Developments
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Information
11.5.2 Hologic, Inc. Cancer Biopsy Product Offered
11.5.3 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hologic, Inc. Main Business Overview
11.5.5 Hologic, Inc. Latest Developments
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Information
11.6.2 Biocept, Inc. Cancer Biopsy Product Offered
11.6.3 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biocept, Inc. Main Business Overview
11.6.5 Biocept, Inc. Latest Developments
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Information
11.7.2 Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.7.5 Thermo Fisher Scientific, Inc. Latest Developments
11.8 Danaher
11.8.1 Danaher Company Information
11.8.2 Danaher Cancer Biopsy Product Offered
11.8.3 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Danaher Main Business Overview
11.8.5 Danaher Latest Developments
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Information
11.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lucence Diagnostics Pte. Ltd. Main Business Overview
11.9.5 Lucence Diagnostics Pte. Ltd. Latest Developments
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Information
11.10.2 GRAIL, Inc. Cancer Biopsy Product Offered
11.10.3 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GRAIL, Inc. Main Business Overview
11.10.5 GRAIL, Inc. Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Cancer Biopsy Product Offered
11.11.3 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Information
11.12.2 Exact Sciences Corporation Cancer Biopsy Product Offered
11.12.3 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exact Sciences Corporation Main Business Overview
11.12.5 Exact Sciences Corporation Latest Developments
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Information
11.13.2 Freenome Holdings, Inc. Cancer Biopsy Product Offered
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Freenome Holdings, Inc. Main Business Overview
11.13.5 Freenome Holdings, Inc. Latest Developments
11.14 Oncimmune
11.14.1 Oncimmune Company Information
11.14.2 Oncimmune Cancer Biopsy Product Offered
11.14.3 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Oncimmune Main Business Overview
11.14.5 Oncimmune Latest Developments
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Information
11.15.2 Chronix Biomedical, Inc. Cancer Biopsy Product Offered
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Chronix Biomedical, Inc. Main Business Overview
11.15.5 Chronix Biomedical, Inc. Latest Developments
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Information
11.16.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Personal Genome Diagnostics Inc. Main Business Overview
11.16.5 Personal Genome Diagnostics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Biopsy Market Size 2019-2030
2.1.2 Cancer Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Biopsy Segment by Type
2.2.1 Tissue Biopsies
2.2.2 Liquid Biopsies
2.2.3 Others
2.3 Cancer Biopsy Market Size by Type
2.3.1 Cancer Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Biopsy Market Size Market Share by Type (2019-2024)
2.4 Cancer Biopsy Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Cervical Cancers
2.4.4 Lung Cancers
2.4.5 Prostate Cancers
2.4.6 Skin Cancers
2.4.7 Blood Cancers
2.4.8 Kidney Cancers
2.4.9 Others
2.5 Cancer Biopsy Market Size by Application
2.5.1 Cancer Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Biopsy Market Size Market Share by Application (2019-2024)
3 CANCER BIOPSY MARKET SIZE BY PLAYER
3.1 Cancer Biopsy Market Size Market Share by Players
3.1.1 Global Cancer Biopsy Revenue by Players (2019-2024)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER BIOPSY BY REGIONS
4.1 Cancer Biopsy Market Size by Regions (2019-2024)
4.2 Americas Cancer Biopsy Market Size Growth (2019-2024)
4.3 APAC Cancer Biopsy Market Size Growth (2019-2024)
4.4 Europe Cancer Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Biopsy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Biopsy Market Size by Country (2019-2024)
5.2 Americas Cancer Biopsy Market Size by Type (2019-2024)
5.3 Americas Cancer Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Biopsy Market Size by Region (2019-2024)
6.2 APAC Cancer Biopsy Market Size by Type (2019-2024)
6.3 APAC Cancer Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Biopsy by Country (2019-2024)
7.2 Europe Cancer Biopsy Market Size by Type (2019-2024)
7.3 Europe Cancer Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Biopsy by Region (2019-2024)
8.2 Middle East & Africa Cancer Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER BIOPSY MARKET FORECAST
10.1 Global Cancer Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Cancer Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Biopsy Forecast
10.1.3 APAC Cancer Biopsy Forecast
10.1.4 Europe Cancer Biopsy Forecast
10.1.5 Middle East & Africa Cancer Biopsy Forecast
10.2 Americas Cancer Biopsy Forecast by Country (2025-2030)
10.2.1 United States Cancer Biopsy Market Forecast
10.2.2 Canada Cancer Biopsy Market Forecast
10.2.3 Mexico Cancer Biopsy Market Forecast
10.2.4 Brazil Cancer Biopsy Market Forecast
10.3 APAC Cancer Biopsy Forecast by Region (2025-2030)
10.3.1 China Cancer Biopsy Market Forecast
10.3.2 Japan Cancer Biopsy Market Forecast
10.3.3 Korea Cancer Biopsy Market Forecast
10.3.4 Southeast Asia Cancer Biopsy Market Forecast
10.3.5 India Cancer Biopsy Market Forecast
10.3.6 Australia Cancer Biopsy Market Forecast
10.4 Europe Cancer Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Cancer Biopsy Market Forecast
10.4.2 France Cancer Biopsy Market Forecast
10.4.3 UK Cancer Biopsy Market Forecast
10.4.4 Italy Cancer Biopsy Market Forecast
10.4.5 Russia Cancer Biopsy Market Forecast
10.5 Middle East & Africa Cancer Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Biopsy Market Forecast
10.5.2 South Africa Cancer Biopsy Market Forecast
10.5.3 Israel Cancer Biopsy Market Forecast
10.5.4 Turkey Cancer Biopsy Market Forecast
10.5.5 GCC Countries Cancer Biopsy Market Forecast
10.6 Global Cancer Biopsy Forecast by Type (2025-2030)
10.7 Global Cancer Biopsy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Information
11.1.2 Qiagen N.V. Cancer Biopsy Product Offered
11.1.3 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Qiagen N.V. Main Business Overview
11.1.5 Qiagen N.V. Latest Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Information
11.2.2 Illumina, Inc. Cancer Biopsy Product Offered
11.2.3 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina, Inc. Main Business Overview
11.2.5 Illumina, Inc. Latest Developments
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Information
11.3.2 ANGLE Plc Cancer Biopsy Product Offered
11.3.3 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ANGLE Plc Main Business Overview
11.3.5 ANGLE Plc Latest Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Information
11.4.2 Myriad Genetics Cancer Biopsy Product Offered
11.4.3 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Myriad Genetics Main Business Overview
11.4.5 Myriad Genetics Latest Developments
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Information
11.5.2 Hologic, Inc. Cancer Biopsy Product Offered
11.5.3 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hologic, Inc. Main Business Overview
11.5.5 Hologic, Inc. Latest Developments
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Information
11.6.2 Biocept, Inc. Cancer Biopsy Product Offered
11.6.3 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biocept, Inc. Main Business Overview
11.6.5 Biocept, Inc. Latest Developments
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Information
11.7.2 Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.7.5 Thermo Fisher Scientific, Inc. Latest Developments
11.8 Danaher
11.8.1 Danaher Company Information
11.8.2 Danaher Cancer Biopsy Product Offered
11.8.3 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Danaher Main Business Overview
11.8.5 Danaher Latest Developments
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Information
11.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lucence Diagnostics Pte. Ltd. Main Business Overview
11.9.5 Lucence Diagnostics Pte. Ltd. Latest Developments
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Information
11.10.2 GRAIL, Inc. Cancer Biopsy Product Offered
11.10.3 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GRAIL, Inc. Main Business Overview
11.10.5 GRAIL, Inc. Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Cancer Biopsy Product Offered
11.11.3 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Information
11.12.2 Exact Sciences Corporation Cancer Biopsy Product Offered
11.12.3 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exact Sciences Corporation Main Business Overview
11.12.5 Exact Sciences Corporation Latest Developments
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Information
11.13.2 Freenome Holdings, Inc. Cancer Biopsy Product Offered
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Freenome Holdings, Inc. Main Business Overview
11.13.5 Freenome Holdings, Inc. Latest Developments
11.14 Oncimmune
11.14.1 Oncimmune Company Information
11.14.2 Oncimmune Cancer Biopsy Product Offered
11.14.3 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Oncimmune Main Business Overview
11.14.5 Oncimmune Latest Developments
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Information
11.15.2 Chronix Biomedical, Inc. Cancer Biopsy Product Offered
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Chronix Biomedical, Inc. Main Business Overview
11.15.5 Chronix Biomedical, Inc. Latest Developments
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Information
11.16.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Personal Genome Diagnostics Inc. Main Business Overview
11.16.5 Personal Genome Diagnostics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Biopsy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Tissue Biopsies
Table 3. Major Players of Liquid Biopsies
Table 4. Major Players of Others
Table 5. Cancer Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 8. Cancer Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 11. Global Cancer Biopsy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cancer Biopsy Revenue Market Share by Player (2019-2024)
Table 13. Cancer Biopsy Key Players Head office and Products Offered
Table 14. Cancer Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cancer Biopsy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cancer Biopsy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cancer Biopsy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cancer Biopsy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cancer Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cancer Biopsy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cancer Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cancer Biopsy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cancer Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cancer Biopsy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cancer Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cancer Biopsy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cancer Biopsy
Table 46. Key Market Challenges & Risks of Cancer Biopsy
Table 47. Key Industry Trends of Cancer Biopsy
Table 48. Global Cancer Biopsy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cancer Biopsy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cancer Biopsy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cancer Biopsy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Qiagen N.V. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 53. Qiagen N.V. Cancer Biopsy Product Offered
Table 54. Qiagen N.V. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Qiagen N.V. Main Business
Table 56. Qiagen N.V. Latest Developments
Table 57. Illumina, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 58. Illumina, Inc. Cancer Biopsy Product Offered
Table 59. Illumina, Inc. Main Business
Table 60. Illumina, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Illumina, Inc. Latest Developments
Table 62. ANGLE Plc Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 63. ANGLE Plc Cancer Biopsy Product Offered
Table 64. ANGLE Plc Main Business
Table 65. ANGLE Plc Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. ANGLE Plc Latest Developments
Table 67. Myriad Genetics Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 68. Myriad Genetics Cancer Biopsy Product Offered
Table 69. Myriad Genetics Main Business
Table 70. Myriad Genetics Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Myriad Genetics Latest Developments
Table 72. Hologic, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 73. Hologic, Inc. Cancer Biopsy Product Offered
Table 74. Hologic, Inc. Main Business
Table 75. Hologic, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Hologic, Inc. Latest Developments
Table 77. Biocept, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 78. Biocept, Inc. Cancer Biopsy Product Offered
Table 79. Biocept, Inc. Main Business
Table 80. Biocept, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Biocept, Inc. Latest Developments
Table 82. Thermo Fisher Scientific, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 83. Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
Table 84. Thermo Fisher Scientific, Inc. Main Business
Table 85. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Thermo Fisher Scientific, Inc. Latest Developments
Table 87. Danaher Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 88. Danaher Cancer Biopsy Product Offered
Table 89. Danaher Main Business
Table 90. Danaher Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Danaher Latest Developments
Table 92. Lucence Diagnostics Pte. Ltd. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 93. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
Table 94. Lucence Diagnostics Pte. Ltd. Main Business
Table 95. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Lucence Diagnostics Pte. Ltd. Latest Developments
Table 97. GRAIL, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 98. GRAIL, Inc. Cancer Biopsy Product Offered
Table 99. GRAIL, Inc. Main Business
Table 100. GRAIL, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GRAIL, Inc. Latest Developments
Table 102. Guardant Health Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 103. Guardant Health Cancer Biopsy Product Offered
Table 104. Guardant Health Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Guardant Health Main Business
Table 106. Guardant Health Latest Developments
Table 107. Exact Sciences Corporation Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 108. Exact Sciences Corporation Cancer Biopsy Product Offered
Table 109. Exact Sciences Corporation Main Business
Table 110. Exact Sciences Corporation Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Exact Sciences Corporation Latest Developments
Table 112. Freenome Holdings, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 113. Freenome Holdings, Inc. Cancer Biopsy Product Offered
Table 114. Freenome Holdings, Inc. Main Business
Table 115. Freenome Holdings, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Freenome Holdings, Inc. Latest Developments
Table 117. Oncimmune Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 118. Oncimmune Cancer Biopsy Product Offered
Table 119. Oncimmune Main Business
Table 120. Oncimmune Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Oncimmune Latest Developments
Table 122. Chronix Biomedical, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 123. Chronix Biomedical, Inc. Cancer Biopsy Product Offered
Table 124. Chronix Biomedical, Inc. Main Business
Table 125. Chronix Biomedical, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Chronix Biomedical, Inc. Latest Developments
Table 127. Personal Genome Diagnostics Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 128. Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
Table 129. Personal Genome Diagnostics Inc. Main Business
Table 130. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Personal Genome Diagnostics Inc. Latest Developments
Table 1. Cancer Biopsy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Tissue Biopsies
Table 3. Major Players of Liquid Biopsies
Table 4. Major Players of Others
Table 5. Cancer Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 8. Cancer Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 11. Global Cancer Biopsy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cancer Biopsy Revenue Market Share by Player (2019-2024)
Table 13. Cancer Biopsy Key Players Head office and Products Offered
Table 14. Cancer Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cancer Biopsy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cancer Biopsy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cancer Biopsy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cancer Biopsy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cancer Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cancer Biopsy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cancer Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cancer Biopsy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cancer Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cancer Biopsy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cancer Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cancer Biopsy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cancer Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cancer Biopsy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cancer Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cancer Biopsy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cancer Biopsy
Table 46. Key Market Challenges & Risks of Cancer Biopsy
Table 47. Key Industry Trends of Cancer Biopsy
Table 48. Global Cancer Biopsy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cancer Biopsy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cancer Biopsy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cancer Biopsy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Qiagen N.V. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 53. Qiagen N.V. Cancer Biopsy Product Offered
Table 54. Qiagen N.V. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Qiagen N.V. Main Business
Table 56. Qiagen N.V. Latest Developments
Table 57. Illumina, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 58. Illumina, Inc. Cancer Biopsy Product Offered
Table 59. Illumina, Inc. Main Business
Table 60. Illumina, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Illumina, Inc. Latest Developments
Table 62. ANGLE Plc Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 63. ANGLE Plc Cancer Biopsy Product Offered
Table 64. ANGLE Plc Main Business
Table 65. ANGLE Plc Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. ANGLE Plc Latest Developments
Table 67. Myriad Genetics Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 68. Myriad Genetics Cancer Biopsy Product Offered
Table 69. Myriad Genetics Main Business
Table 70. Myriad Genetics Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Myriad Genetics Latest Developments
Table 72. Hologic, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 73. Hologic, Inc. Cancer Biopsy Product Offered
Table 74. Hologic, Inc. Main Business
Table 75. Hologic, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Hologic, Inc. Latest Developments
Table 77. Biocept, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 78. Biocept, Inc. Cancer Biopsy Product Offered
Table 79. Biocept, Inc. Main Business
Table 80. Biocept, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Biocept, Inc. Latest Developments
Table 82. Thermo Fisher Scientific, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 83. Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
Table 84. Thermo Fisher Scientific, Inc. Main Business
Table 85. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Thermo Fisher Scientific, Inc. Latest Developments
Table 87. Danaher Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 88. Danaher Cancer Biopsy Product Offered
Table 89. Danaher Main Business
Table 90. Danaher Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Danaher Latest Developments
Table 92. Lucence Diagnostics Pte. Ltd. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 93. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
Table 94. Lucence Diagnostics Pte. Ltd. Main Business
Table 95. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Lucence Diagnostics Pte. Ltd. Latest Developments
Table 97. GRAIL, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 98. GRAIL, Inc. Cancer Biopsy Product Offered
Table 99. GRAIL, Inc. Main Business
Table 100. GRAIL, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GRAIL, Inc. Latest Developments
Table 102. Guardant Health Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 103. Guardant Health Cancer Biopsy Product Offered
Table 104. Guardant Health Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Guardant Health Main Business
Table 106. Guardant Health Latest Developments
Table 107. Exact Sciences Corporation Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 108. Exact Sciences Corporation Cancer Biopsy Product Offered
Table 109. Exact Sciences Corporation Main Business
Table 110. Exact Sciences Corporation Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Exact Sciences Corporation Latest Developments
Table 112. Freenome Holdings, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 113. Freenome Holdings, Inc. Cancer Biopsy Product Offered
Table 114. Freenome Holdings, Inc. Main Business
Table 115. Freenome Holdings, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Freenome Holdings, Inc. Latest Developments
Table 117. Oncimmune Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 118. Oncimmune Cancer Biopsy Product Offered
Table 119. Oncimmune Main Business
Table 120. Oncimmune Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Oncimmune Latest Developments
Table 122. Chronix Biomedical, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 123. Chronix Biomedical, Inc. Cancer Biopsy Product Offered
Table 124. Chronix Biomedical, Inc. Main Business
Table 125. Chronix Biomedical, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Chronix Biomedical, Inc. Latest Developments
Table 127. Personal Genome Diagnostics Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
Table 128. Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
Table 129. Personal Genome Diagnostics Inc. Main Business
Table 130. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Personal Genome Diagnostics Inc. Latest Developments
LIST OF FIGURES
Figure 1. Cancer Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Biopsy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Biopsy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Biopsy Sales Market Share by Country/Region (2023)
Figure 8. Cancer Biopsy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Biopsy Market Size Market Share by Type in 2023
Figure 10. Cancer Biopsy in Breast Cancer
Figure 11. Global Cancer Biopsy Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 12. Cancer Biopsy in Colorectal Cancer
Figure 13. Global Cancer Biopsy Market: Colorectal Cancer (2019-2024) & ($ Millions)
Figure 14. Cancer Biopsy in Cervical Cancers
Figure 15. Global Cancer Biopsy Market: Cervical Cancers (2019-2024) & ($ Millions)
Figure 16. Cancer Biopsy in Lung Cancers
Figure 17. Global Cancer Biopsy Market: Lung Cancers (2019-2024) & ($ Millions)
Figure 18. Cancer Biopsy in Prostate Cancers
Figure 19. Global Cancer Biopsy Market: Prostate Cancers (2019-2024) & ($ Millions)
Figure 20. Cancer Biopsy in Skin Cancers
Figure 21. Global Cancer Biopsy Market: Skin Cancers (2019-2024) & ($ Millions)
Figure 22. Cancer Biopsy in Blood Cancers
Figure 23. Global Cancer Biopsy Market: Blood Cancers (2019-2024) & ($ Millions)
Figure 24. Cancer Biopsy in Kidney Cancers
Figure 25. Global Cancer Biopsy Market: Kidney Cancers (2019-2024) & ($ Millions)
Figure 26. Cancer Biopsy in Others
Figure 27. Global Cancer Biopsy Market: Others (2019-2024) & ($ Millions)
Figure 28. Global Cancer Biopsy Market Size Market Share by Application in 2023
Figure 29. Global Cancer Biopsy Revenue Market Share by Player in 2023
Figure 30. Global Cancer Biopsy Market Size Market Share by Regions (2019-2024)
Figure 31. Americas Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 32. APAC Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 33. Europe Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 35. Americas Cancer Biopsy Value Market Share by Country in 2023
Figure 36. United States Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Canada Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Mexico Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Brazil Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 40. APAC Cancer Biopsy Market Size Market Share by Region in 2023
Figure 41. APAC Cancer Biopsy Market Size Market Share by Type in 2023
Figure 42. APAC Cancer Biopsy Market Size Market Share by Application in 2023
Figure 43. China Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Japan Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Korea Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Southeast Asia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 47. India Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 48. Australia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 49. Europe Cancer Biopsy Market Size Market Share by Country in 2023
Figure 50. Europe Cancer Biopsy Market Size Market Share by Type (2019-2024)
Figure 51. Europe Cancer Biopsy Market Size Market Share by Application (2019-2024)
Figure 52. Germany Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 53. France Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 54. UK Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Italy Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 56. Russia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 57. Middle East & Africa Cancer Biopsy Market Size Market Share by Region (2019-2024)
Figure 58. Middle East & Africa Cancer Biopsy Market Size Market Share by Type (2019-2024)
Figure 59. Middle East & Africa Cancer Biopsy Market Size Market Share by Application (2019-2024)
Figure 60. Egypt Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 61. South Africa Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 62. Israel Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 63. Turkey Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 64. GCC Country Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 65. Americas Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 66. APAC Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 67. Europe Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 68. Middle East & Africa Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 69. United States Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 70. Canada Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 71. Mexico Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 72. Brazil Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 73. China Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 74. Japan Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 75. Korea Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 76. Southeast Asia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 77. India Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 78. Australia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 79. Germany Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 80. France Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 81. UK Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 82. Italy Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 83. Russia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 84. Spain Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 85. Egypt Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 86. South Africa Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 87. Israel Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 88. Turkey Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 89. GCC Countries Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 90. Global Cancer Biopsy Market Size Market Share Forecast by Type (2025-2030)
Figure 91. Global Cancer Biopsy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cancer Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Biopsy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Biopsy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Biopsy Sales Market Share by Country/Region (2023)
Figure 8. Cancer Biopsy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Biopsy Market Size Market Share by Type in 2023
Figure 10. Cancer Biopsy in Breast Cancer
Figure 11. Global Cancer Biopsy Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 12. Cancer Biopsy in Colorectal Cancer
Figure 13. Global Cancer Biopsy Market: Colorectal Cancer (2019-2024) & ($ Millions)
Figure 14. Cancer Biopsy in Cervical Cancers
Figure 15. Global Cancer Biopsy Market: Cervical Cancers (2019-2024) & ($ Millions)
Figure 16. Cancer Biopsy in Lung Cancers
Figure 17. Global Cancer Biopsy Market: Lung Cancers (2019-2024) & ($ Millions)
Figure 18. Cancer Biopsy in Prostate Cancers
Figure 19. Global Cancer Biopsy Market: Prostate Cancers (2019-2024) & ($ Millions)
Figure 20. Cancer Biopsy in Skin Cancers
Figure 21. Global Cancer Biopsy Market: Skin Cancers (2019-2024) & ($ Millions)
Figure 22. Cancer Biopsy in Blood Cancers
Figure 23. Global Cancer Biopsy Market: Blood Cancers (2019-2024) & ($ Millions)
Figure 24. Cancer Biopsy in Kidney Cancers
Figure 25. Global Cancer Biopsy Market: Kidney Cancers (2019-2024) & ($ Millions)
Figure 26. Cancer Biopsy in Others
Figure 27. Global Cancer Biopsy Market: Others (2019-2024) & ($ Millions)
Figure 28. Global Cancer Biopsy Market Size Market Share by Application in 2023
Figure 29. Global Cancer Biopsy Revenue Market Share by Player in 2023
Figure 30. Global Cancer Biopsy Market Size Market Share by Regions (2019-2024)
Figure 31. Americas Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 32. APAC Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 33. Europe Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Cancer Biopsy Market Size 2019-2024 ($ Millions)
Figure 35. Americas Cancer Biopsy Value Market Share by Country in 2023
Figure 36. United States Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Canada Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Mexico Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Brazil Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 40. APAC Cancer Biopsy Market Size Market Share by Region in 2023
Figure 41. APAC Cancer Biopsy Market Size Market Share by Type in 2023
Figure 42. APAC Cancer Biopsy Market Size Market Share by Application in 2023
Figure 43. China Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Japan Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Korea Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Southeast Asia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 47. India Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 48. Australia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 49. Europe Cancer Biopsy Market Size Market Share by Country in 2023
Figure 50. Europe Cancer Biopsy Market Size Market Share by Type (2019-2024)
Figure 51. Europe Cancer Biopsy Market Size Market Share by Application (2019-2024)
Figure 52. Germany Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 53. France Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 54. UK Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Italy Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 56. Russia Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 57. Middle East & Africa Cancer Biopsy Market Size Market Share by Region (2019-2024)
Figure 58. Middle East & Africa Cancer Biopsy Market Size Market Share by Type (2019-2024)
Figure 59. Middle East & Africa Cancer Biopsy Market Size Market Share by Application (2019-2024)
Figure 60. Egypt Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 61. South Africa Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 62. Israel Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 63. Turkey Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 64. GCC Country Cancer Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 65. Americas Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 66. APAC Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 67. Europe Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 68. Middle East & Africa Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 69. United States Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 70. Canada Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 71. Mexico Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 72. Brazil Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 73. China Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 74. Japan Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 75. Korea Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 76. Southeast Asia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 77. India Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 78. Australia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 79. Germany Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 80. France Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 81. UK Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 82. Italy Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 83. Russia Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 84. Spain Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 85. Egypt Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 86. South Africa Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 87. Israel Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 88. Turkey Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 89. GCC Countries Cancer Biopsy Market Size 2025-2030 ($ Millions)
Figure 90. Global Cancer Biopsy Market Size Market Share Forecast by Type (2025-2030)
Figure 91. Global Cancer Biopsy Market Size Market Share Forecast by Application (2025-2030)
